Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype BEFREE These findings highlight the importance of mental health of females before pregnancy and suggest that CUS before pregnancy reduces p-CREB and p-NR2B in the offspring hippocampus, which could be responsible for behavioral disorders in the adolescent offspring. 31419724 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 GeneticVariation phenotype CLINVAR
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype BEFREE GRIN2B encodes a subunit of NMDARs, and has been identified as a candidate gene for many psychiatric disorders, especially schizophrenia. 27453061 2016
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype HPO
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype BEFREE Taken together, our results revealed a specific enhancement of GluN2B-containing NMDARs by 24HC, indicating a novel endogenous pathway to influence a subclass of NMDARs critically involved in cortical plasticity and in numerous neurological and psychiatric disorders. 30594698 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype BEFREE NR2B Y1472 is hypophosphorylated in NRG1+/- mutant mice, and this defect can be reversed by clozapine at a dose that reverses their behavioral abnormalities. 17460065 2007
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 Biomarker phenotype BEFREE In wild-type mice, systemic treatment with the NR2B antagonist, Ro25-6981 [R-(R,S)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propranol], and hippocampal small interfering RNA-mediated NR2B/Grin2b knockdown resulted in behavioral changes similar to those elicited by the Setdb1 transgene. 20505083 2010
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 AlteredExpression phenotype BEFREE The pathogenic relevance of NMDAR autoantibodies to behavioral abnormalities (blunted response to amphetamine-triggered activity and decreased locomotor activity and exploration) and reduced expression of synaptic proteins (the GLUN2B subtype of NMDAR and PSD-95) has been demonstrated in infected mice. 30037790 2018
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 GeneticVariation phenotype BEFREE Mutations in the GRIN2B gene (MRD6, MIM613970) have been identified as a common cause of ID (prevalence of 0.5 - 1% in individuals with ID) associated with EEG and behavioral problems. 23718928 2013
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.180 AlteredExpression phenotype BEFREE We also used gap-prepulse inhibition of the acoustic startle reflex (GPIAS) and noise burst prepulse inhibition of acoustic startle, and the auditory brainstem level (electrophysiological recordings of auditory brainstem responses, ABR) and NR2B expression level in the auditory cortex to evaluate whether memantine could reduce salicylate-mediated behavioral disturbances. 31495078 2019
CUI: C4023528
Disease: Abnormality of skin morphology
Abnormality of skin morphology
0.100 Biomarker phenotype HPO
CUI: C1854882
Disease: Absent speech
Absent speech
0.100 Biomarker phenotype HPO
CUI: C1854882
Disease: Absent speech
Absent speech
0.100 GeneticVariation phenotype CLINVAR
CUI: C4317146
Disease: Acid reflux
Acid reflux
0.100 GeneticVariation phenotype CLINVAR
CUI: C0751956
Disease: Acute Cerebrovascular Accidents
Acute Cerebrovascular Accidents
0.010 Biomarker disease BEFREE Recent findings have provided insights into the pathophysiology and mechanisms of ischemic stroke, complementing the traditional glutamate hypothesis: the molecular interaction between PSD95 and GluN2B has been identified as a culprit in stroke-mediated excitotoxicity, leading to the discovery of NA-1, a peptide that disrupts that interaction, as a potent neuroprotective agent for the treatment of acute stroke. 29565039 2018
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.020 AlteredExpression phenotype BEFREE Data obtained using Western blotting technique showed a significant increase in the level of GluN1 and GluN2B, but not in GluN2A subunits in all the three regions (mPFC, lPFC, and OFC) of men whom suffered from addiction as compared to the appropriate controls. 29766293 2019
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.020 Biomarker phenotype BEFREE Therefore, our results reveal that enhanced pSer187-SNAP25 by PKC recruits GluN2B-NMDAR to the membrane surface in the hippocampal CA1 and mediates context-induced addiction memory retrieval. 28884870 2018
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 Biomarker disease BEFREE Administration of NMDA receptor subunit NR2B antagonist Ro 25-6981 into the ACC significantly alleviated the potentiation of MT stimulation-evoked LFP in the ACC of EOI rats without affecting that in control rats. 30786804 2019
CUI: C0001956
Disease: Alcohol Use Disorder
Alcohol Use Disorder
0.020 Biomarker disease BEFREE The GRIN2B gene is involved in glutamatergic signalling and may be associated with developmental differences in AUD in brain regions such as the posterior cingulate cortex. 27498914 2017
CUI: C0001956
Disease: Alcohol Use Disorder
Alcohol Use Disorder
0.020 Biomarker disease BEFREE The pathway analysis provided overall negative findings, although several genes including GRIN2B showed high percentage of associated SNPs for BD-AUD. 26563126 2016
CUI: C0236663
Disease: Alcohol withdrawal syndrome
Alcohol withdrawal syndrome
0.020 GeneticVariation disease BEFREE The associations of GRIN2B polymorphism (rs1806201) with alcohol withdrawal and related clinical parameters in alcohol dependent subjects were investigated. 26771436 2017
CUI: C0236663
Disease: Alcohol withdrawal syndrome
Alcohol withdrawal syndrome
0.020 PosttranslationalModification disease BEFREE N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal. 19350219 2009
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.380 Biomarker disease PSYGENET These findings suggest new candidate SNPs in GRIN2B for studying the genetic susceptibility to alcoholism. 16911840 2006
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.380 GeneticVariation disease BEFREE GABRB2 and GRIN2B genotypes were associated with significant regional differences in the pattern of beta subunit expression, but this was not influenced by alcoholism status. 16766085 2006
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.380 Biomarker disease LHGDN These findings suggest new candidate SNPs in GRIN2B for studying the genetic susceptibility to alcoholism. 16911840 2006